Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Secondary Analysis Of The CANTOS Trial: Differential Impact Of Residual Inflammatory Risk And Residual Cholesterol Risk Among Atherosclerosis Patients With And Without Chronic Kidney Disease April 4, 2022 Disclosures: TBA
Dr. Marie-Sophie De Koning and Dr. C. Michael Gibson Discuss: GIPS-IV: The Groningen Intervention Study For The Preservation Of Cardiac Function With Sodium Thiosulfate After St-segment Elevation Myocardial Infarction April 4, 2022 Disclosures: TBA
Dr. Bon-Kwon Koo and Dr. C. Michael Gibson Discuss: The FLAVOUR Randomized Clinical Trial: Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis April 4, 2022 Disclosures: TBA
Dr. Duk-Woo Park and Dr. C. Michael Gibson Discuss: A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement April 4, 2022 Disclosures: TBA
Dr. Michael Reardon and Dr. Yazan Daaboul Discuss: Insights From The Corevalve US Pivotal And SURTAVI Trials: Five-year Incidence, Timing And Predictors Of Hemodynamic Valve Deterioration Of Transcatheter And Surgical Aortic Bioprostheses April 4, 2022 Disclosures: TBA
Dr. Adam Greenbaum and Dr. Serge Korjian Discuss: One-year Results Of The Clasp TR Study: Transcatheter Treatment Of Tricuspid Regurgitation April 4, 2022 Disclosures: TBA
Dr. Maura Marcucci and Dr. Yazan Daaboul Discuss: POISE-3: The Effects Of A Hypotension-avoidance Strategy Versus A Hypertension-avoidance Strategy In Patients Undergoing Noncardiac Surgery April 4, 2022 Disclosures: TBA
Dr. Daniel Sessler and Dr. C. Michael Gibson Discuss: The PROTECT Trial: Very Mild Perioperative Hypothermia Versus Aggressive Warming And Myocardial Injury After Non-cardiac Surgery April 4, 2022 Disclosures: TBA
Dr. Manesh Patel and Dr. C. Michael Gibson Discuss: PACIFIC AF: Multicenter, Randomized, Active Comparator-controlled, Double-blind, Double-dummy, Parallel Group, Dose-finding Phase 2 Study Comparing The Safety Of The Oral FXIa Inhibitor Asundexian With Apixaban In Patients With Atrial Fibrillation April 3, 2022 Disclosures: TBA
Dr. Mark Loeb and Dr. C. Michael Gibson Discuss: IVVE: Randomized Controlled Trial Of Influenza Vaccine In Patients With Heart Failure To Reduce Adverse Vascular Events April 3, 2022 Disclosures: TBA
